4.3 Article

Trends in colorectal cancer mortality in hispanics: a SEER analysis

Journal

ONCOTARGET
Volume 8, Issue 65, Pages 108771-108777

Publisher

IMPACT JOURNALS LLC
DOI: 10.18632/oncotarget.21938

Keywords

hispanics; SEER; outcome; colorectal cancer; disparity

Funding

  1. National Cancer Institute [P30CA014089]

Ask authors/readers for more resources

Background: Colorectal cancer (CRC) mortality among Hispanics is lower than Non-Hispanic Whites (NHW). If Hispanics receive equitable care and achieve the same degree of health benefit, their trend of better survival should be maintained. This study assesses mortality trends among Hispanics overtime to compare their survival improvement with NHW. Methods: We used the Incidence-Based Mortality database of the Surveillance, Epidemiology, and End Results Program (SEER) to assess the mortality gap, which is defined as the difference in stage-specific mortality between NHWs and Hispanics, and currently has an advantage for Hispanics. Results: There is a statistically significant disparity in stage-specific mortality of CRC by race, with a higher proportion of deaths from metastatic disease among Hispanics than NHW (48% vs. 44% respectively). Comparing the time intervals of 2000-2005 and 2006-2011, mortality was reduced by 15.1% for NHWs and 5.9% for Hispanics, resulting in a narrowing of the mortality gap. The mortality gap between Hispanics and NHW is tapering overtime for every stage of the disease, reflecting that Hispanics have a disparity in CRC mortality. Conclusion: The mortality gap between Hispanics and NHWs is narrowing, supporting a significantly lower rate of mortality improvement in Hispanics. If the current trend continues, mortality rates in Hispanics will outpace that of NHWs.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.3
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Health Care Sciences & Services

Understanding the patient experience in hepatocellular carcinoma: a qualitative patient interview study

Nikunj Patel, Joshua Maher, Xandra Lie, Chad Gwaltney, Afsaneh Barzi, Mark Karwal, Teresa Macarulla, Hui-Chuan Sun, Jorg Trojan, Oren Meyers, Christina Workman, Shethah Morgan, Alejandra Negro, Gordon Cohen

Summary: Patients with hepatocellular carcinoma (HCC) experience a range of signs/symptoms and impacts that negatively affect their daily functioning and quality of life, with fatigue/lack of energy and emotional impacts being the most prevalent and disturbing across disease stages. Including patient-reported outcome measures in HCC clinical trials can provide valuable insights for drug development.

QUALITY OF LIFE RESEARCH (2022)

Article Oncology

Impacts of the SARS-CoV-2 Pandemic on Young Adult Colorectal Cancer Survivors

Kimberly A. Miller, Dalia Kagramanov, Sally Cohen-Cutler, Bahram Nadim, Zhen Weng, Phuong Gallagher, Jonathan N. Kaslander, David R. Freyer, Afsaneh Barzi, Heinz-Josef Lenz

Summary: The SARS-CoV-2 pandemic has significantly impacted young adult colorectal cancer survivors, leading to delays in cancer-related care, income loss, and poorer mental health. Survivors aged 20-29 are particularly affected, with a majority experiencing delays in cancer care and income loss, highlighting the need for specific support and resources.

JOURNAL OF ADOLESCENT AND YOUNG ADULT ONCOLOGY (2022)

Meeting Abstract Oncology

A phase Ib study of guadecitabine and durvalumab in patients with advanced hepatocellular carcinoma, pancreatic adenocarcinoma, and biliary cancers

Sandra Algaze, Diana L. Hanna, Nilofer Saba Azad, Jacob Stephen Thomas, Syma Iqbal, Diane Habib, Yan Ning, Afsaneh Barzi, Ronak Patel, Heinz-Josef Lenz, Anthony B. El-Khoueiry

JOURNAL OF CLINICAL ONCOLOGY (2022)

Meeting Abstract Oncology

Prevalence of information needs among emerging and young adult colorectal cancer survivors

Serena Yi, Karli Rodriguez, Julia Stal, Sally Cohen-Cutler, Phuong Gallagher, Afsaneh Barzi, David R. Freyer, Joel Milam, Heinz-Josef Lenz, Kimberly Ann Miller

JOURNAL OF CLINICAL ONCOLOGY (2022)

Meeting Abstract Oncology

Patient care satisfaction and emergency room utilization among young adult colorectal cancer survivors during the SARS-CoV-2 pandemic

Dalia Kagramanov, Kimberly Ann Miller, Phuong Gallagher, David R. Freyer, Joel Milam, Heinz-Josef Lenz, Afsaneh Barzi

JOURNAL OF CLINICAL ONCOLOGY (2022)

Meeting Abstract Oncology

MOUNTAINEER-02: Phase 2/3 study of tucatinib, trastuzumab, ramucirumab, and paclitaxel in previously treated HER2+gastric or gastroesophageal junction adenocarcinoma-Trial in progress

Daniel V. T. Catenacci, John H. Strickler, Yoshiaki Nakamura, Kohei Shitara, Yelena Y. Janjigian, Afsaneh Barzi, Tanios S. Bekaii-Saab, Heinz-Josef Lenz, Hyun Cheol Cheol Chung, Josep Tabernero, Takayuki Yoshino, Salvatore Siena, Joal Garrido Mayor, Maria Corinna Palanca-Wessels, Diqiong Xie, John Marshall

JOURNAL OF CLINICAL ONCOLOGY (2022)

Meeting Abstract Oncology

Phase I/II study of regorafenib (rego) and pembrolizumab (pembro) in refractory microsatellite stable colorectal cancer (MSSCRC)

Afsaneh Barzi, Nilofer Saba Azad, Yan Yang, Denice Tsao-Wei, Rabia Rehman, Marwan Fakih, Syma Iqbal, Anthony B. El-Khoueiry, Joshua Millstein, Priya Jayachandran, Wu Zhang, Heinz-Josef Lenz

JOURNAL OF CLINICAL ONCOLOGY (2022)

Article Oncology

Long-term follow-up of patients with poor-risk acute leukemia treated on a phase 2 trial undergoing intensified conditioning regimen prior to allogeneic hematopoietic cell transplantation

Amandeep Salhotra, Dongyun Yang, Sally Mokhtari, Susanta Hui, Monzr M. Al Malki, Saro Armenian, Brianna Sigala, Ibrahim Aldoss, Vinod Pullarkat, Stephen Forman, Guido Marcucci, Ryotaro Nakamura, Andrew Artz, Jeffery Wong, Anthony Stein

Summary: The study highlights the benefits of intensive conditioning regimens in improving leukemia free and overall survival rates in high-risk patients with acute leukemia. However, the most common long-term effects include secondary malignancies, metabolic, or cardiac complications.

LEUKEMIA & LYMPHOMA (2022)

Article Oncology

Novel Program Offering Remote, Asynchronous Subspecialist Input in Thoracic Oncology: Early Experience and Insights Gained During the COVID-19 Pandemic

Howard (Jack) West, Yuan Angela Tan, Afsaneh Barzi, Debra Wong, Robert Parsley, Todd Sachs

Summary: AccessHope is a program developed by City of Hope to provide remote specialized input on cancer care. This study focuses on the early development and growth of the program, specifically on lung cancer cases during the COVID-19 pandemic. The study shows the feasibility of this program in improving care and reducing costs.

JCO ONCOLOGY PRACTICE (2022)

Article Medicine, General & Internal

Patient Care Satisfaction and Emergency Room Utilization among Young Adult Colorectal Cancer Survivors during the SARS-CoV-2 Pandemic: Lessons Learned

Dalia Kagramanov, Kimberly A. A. Miller, Phuong Gallagher, David R. R. Freyer, Joel E. E. Milam, Heinz-Josef Lenz, Afsaneh Barzi

Summary: Survivors of colorectal cancer faced challenges in receiving follow-up care and experienced delays in care during the COVID-19 pandemic. This study found that delays in care and lower patient satisfaction were associated with increased utilization of emergency rooms among young adult CRC survivors.

JOURNAL OF CLINICAL MEDICINE (2023)

Article Oncology

The Impact of Facility Surgical Caseload Volumes on Survival Outcomes in Patients Undergoing Radical Cystectomy

Giovanni E. E. Cacciamani, Afsaneh Barzi, Michael B. B. Eppler, Primo N. N. Lara Jr, Chong-Xian Pan, Sumeet K. K. Bhanvadia, Parkash Gill, Monish Aron, Inderbir Gill, Sarmad Sadeghi

Summary: The oncological outcome of curative surgery for urothelial carcinoma of the bladder is influenced by the caseload of the facility and the surgical experience. This study found that as the annual caseload of surgery at the facility decreased, the all-cause mortality for the patients increased significantly. Higher caseload was associated with improved overall survival, highlighting the importance of surgical experience.

CANCERS (2022)

Meeting Abstract Oncology

Multimorbidity and the association with patient reported access to care and physician relationships among racially and ethnically diverse patients with colorectal cancer

Stephanie Navarro, Mariana C. Stern, Afsaneh Barzi, Albert J. Farias

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2023)

Article Oncology

A Phase II Study Investigating Cabozantinib in Patients with Refractory Metastatic Colorectal Cancer (AGICC 17CRC01)

Aaron J. Scott, Atrayee Basu Mallick, Efrat Dotan, Steven J. Cohen, Philip J. Gold, Howard S. Hochster, Somasundaram Subramaniam, Afsaneh Barzi, George S. Watts, Patrick J. Blatchford, Wells A. Messersmith

Summary: This study demonstrated the clinical activity of cabozantinib in patients with refractory metastatic colorectal cancer, suggesting its potential as a therapeutic option.

CANCER RESEARCH COMMUNICATIONS (2022)

Article Gastroenterology & Hepatology

Temporal trends in self-reported general and mental health status among colorectal cancer patients: racial/ethnic disparities in a population-based analysis

Stephanie Navarro, Afsaneh Barzi, Xiayu Jiao, Albert J. Farias

Summary: The diagnosis of colorectal cancer is associated with self-reported general health status and mental health status, and this relationship is influenced by race/ethnicity.

INTERNATIONAL JOURNAL OF COLORECTAL DISEASE (2022)

Article Hematology

Cytokine Release Syndrome Following Peripheral Blood Stem Cell Haploidentical Hematopoietic Cell Transplantation with Post-Transplantation Cyclophosphamide

Salman Otoukesh, Hany Elmariah, Dongyun Yang, Mary C. Clark, Madiha Siraj, Haris Ali, Krishnakar Mogili, Shukaib Arslan, Taiga Nishihori, Ryotaro Nakamura, Joseph Pidala, Guido Marcucci, Stephen J. Forman, Claudio Anasetti, Monzr M. Al Malki, Nelli Bejanyan

Summary: The study found that higher CD3+ cell dose was associated with a higher incidence of CRS and severe CRS, which negatively affected transplantation outcomes, while moderate to severe CRS did not impact relapse or GVHD.

TRANSPLANTATION AND CELLULAR THERAPY (2022)

No Data Available